CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Mar 20, 2024 | Sale | $32.53 | 120,000 | 3,903,125 | 36,036 | Mar 22, 2024, 04:31 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Mar 07, 2024 | Sale | $50.88 | 12,195 | 620,443 | 24,505 | Mar 11, 2024, 12:54 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Jun 07, 2023 | Option Exercise | $51.82 | 3,300 | 171,006 | 27,055 | Jun 09, 2023, 02:32 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Jul 13, 2022 | Sale | $11.20 | 11,400 | 127,720 | 18,236 | Jul 15, 2022, 04:30 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Mar 04, 2022 | Option Exercise | $40.37 | 7,500 | 302,775 | 23,195 | Mar 08, 2022, 12:25 PM |
ATRA | | Atara Biotherapeutics, Inc. | Fust Matthew K | Director | Nov 04, 2021 | Sale | $19.50 | 13,354 | 260,403 | 31,500 | Nov 05, 2021, 04:28 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Nov 01, 2021 | Option Exercise | $13.70 | 17,908 | 245,429 | 21,490 | Nov 03, 2021, 04:55 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Sep 08, 2021 | Option Exercise | $13.70 | 12,092 | 165,721 | 18,582 | Sep 09, 2021, 05:00 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Jul 26, 2021 | Option Exercise | $10.75 | 10,000 | 107,500 | 17,536 | Jul 27, 2021, 08:00 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Jul 19, 2021 | Option Exercise | $10.70 | 10,000 | 107,050 | 17,536 | Jul 20, 2021, 05:00 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Jul 12, 2021 | Option Exercise | $11.31 | 10,000 | 113,100 | 17,536 | Jul 13, 2021, 05:00 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Jul 06, 2020 | Option Exercise | $55.50 | 12,362 | 686,091 | 19,731 | Jul 08, 2020, 12:30 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Jul 01, 2020 | Option Exercise | $53.00 | 10,000 | 530,000 | 18,550 | Jul 06, 2020, 02:21 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | May 18, 2020 | Sale | $75.00 | 1,875 | 140,625 | 11,000 | May 19, 2020, 07:13 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Apr 22, 2020 | Sale | $65.00 | 1,875 | 121,875 | 12,875 | Apr 24, 2020, 01:00 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Feb 20, 2020 | Option Exercise | $18.75 | 5,051 | 94,706 | 0 | Feb 24, 2020, 07:32 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Dec 24, 2019 | Sale | $15.00 | 3,000 | 45,000 | 5,051 | Dec 26, 2019, 04:13 PM |
CRNX | | Crinetics Pharmaceuticals, Inc. | Fust Matthew K | Director | Dec 16, 2019 | Option Exercise | $12.20 | 7,000 | 85,435 | 16,036 | Dec 18, 2019, 06:32 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Dec 12, 2019 | Sale | $12.00 | 3,000 | 36,000 | 8,051 | Dec 13, 2019, 05:13 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Sep 12, 2019 | Sale | $8.77 | 6,000 | 52,636 | 11,051 | Sep 16, 2019, 04:09 PM |
MGNX | | MACROGENICS INC | Fust Matthew K | Director | Feb 06, 2019 | Sale | $24.76 | 13,848 | 342,946 | 7,424 | Feb 08, 2019, 05:41 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Oct 19, 2018 | Sale | $13.75 | 4,000 | 55,000 | 14,051 | Oct 19, 2018, 04:24 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | May 30, 2018 | Sale | $72.00 | 6,319 | 454,969 | 8,750 | May 30, 2018, 07:26 PM |
ATRA | | Atara Biotherapeutics, Inc. | Fust Matthew K | Director | May 14, 2018 | Sale | $43.57 | 12,286 | 535,301 | 19,820 | May 16, 2018, 08:40 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Jun 29, 2015 | Option Exercise | $5.51 | 9,051 | 49,871 | 15,051 | Jun 30, 2015, 04:09 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Mar 19, 2015 | Option Exercise | $21.00 | 6,319 | 132,699 | 11,319 | Mar 23, 2015, 04:16 PM |
DERM | | Dermira, Inc. | Fust Matthew K | Director | Nov 25, 2014 | Buy | $16.77 | 6,000 | 100,604 | 6,000 | Nov 26, 2014, 04:11 PM |
RARE | | Ultragenyx Pharmaceutical Inc. | Fust Matthew K | Director | Jan 30, 2014 | Buy | $21.00 | 5,000 | 105,000 | 5,000 | Feb 03, 2014, 08:34 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Oct 01, 2013 | Option Exercise | $125.00 | 40,303 | 5,037,875 | 31,150 | Oct 03, 2013, 09:18 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Aug 08, 2013 | Sale | $128.21 | 2,492 | 319,499 | 40,303 | Aug 12, 2013, 07:11 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Jul 26, 2013 | Sale | $130.50 | 6,043 | 788,612 | 42,795 | Jul 29, 2013, 07:45 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Jul 02, 2013 | Sale | $132.80 | 1,551 | 205,973 | 48,961 | Jul 05, 2013, 04:03 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | May 13, 2013 | Sale | $66.35 | 20,538 | 1,362,673 | 60,473 | May 15, 2013, 06:51 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Apr 15, 2013 | Sale | $95.15 | 1,347 | 128,167 | 50,204 | Apr 16, 2013, 04:23 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Apr 01, 2013 | Sale | $86.14 | 3,861 | 332,575 | 54,245 | Apr 03, 2013, 07:51 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Mar 05, 2013 | Option Exercise | $34.48 | 2,211 | 76,235 | 47,412 | Mar 05, 2013, 08:14 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Feb 28, 2013 | Option Exercise | $60.06 | 25,000 | 1,501,600 | 60,201 | Mar 04, 2013, 06:39 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Jan 10, 2013 | Sale | $64.17 | 17,311 | 1,110,804 | 60,400 | Jan 11, 2013, 08:32 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | EVP & Chief Financial Officer | Nov 28, 2012 | Option Exercise | $34.48 | 966 | 33,308 | 53,123 | Nov 30, 2012, 07:23 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Aug 06, 2012 | Sale | $55.22 | 39,501 | 2,181,391 | 85,416 | Aug 08, 2012, 09:48 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Jul 25, 2012 | Sale | $73.97 | 5,207 | 385,171 | 67,924 | Jul 27, 2012, 08:23 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Apr 02, 2012 | Option Exercise | $36.58 | 1,577 | 57,682 | 73,630 | Apr 03, 2012, 08:30 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Mar 02, 2012 | Sale | $37.52 | 592 | 22,212 | 48,237 | Mar 06, 2012, 07:21 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Feb 14, 2012 | Option Exercise | $34.48 | 5,000 | 172,400 | 48,829 | Feb 16, 2012, 05:54 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Jan 06, 2012 | Sale | $43.46 | 1,789 | 77,750 | 43,829 | Jan 10, 2012, 05:29 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Nov 18, 2011 | Sale | $38.05 | 867 | 32,989 | 45,310 | Nov 21, 2011, 05:21 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Apr 01, 2011 | Sale | $35.02 | 800 | 28,016 | 45,801 | Apr 04, 2011, 08:25 PM |
ONXX | | ONYX PHARMACEUTICALS INC | Fust Matthew K | Chief Financial Officer | Jan 06, 2011 | Sale | $37.28 | 1,812 | 67,551 | 18,101 | Jan 07, 2011, 07:29 PM |